Literature DB >> 13980540

The estimation of heparin co-factor in serum.

I J TEMPERLEY.   

Abstract

A quantitative method of estimating heparin co-factor in terms of percentage activity is presented. The activity in sera from 75 normal subjects varied little from 100%. Low results were obtained in sera from 50 cases of varying types of malignancy.

Entities:  

Keywords:  BLOOD COAGULATION FACTORS; BLOOD PROTEINS; HEPARIN

Mesh：

Substances：

Year:  1963        PMID： 13980540      PMCID： PMC480509          DOI： 10.1136/jcp.16.2.115

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN： 0021-9746            Impact factor:   3.411


  9 in total

1.  A technique for the heparin-tolerance test.

Authors:  J GORMSEN
Journal:  Br J Haematol       Date:  1959-07       Impact factor: 6.998

2.  Studies on increased heparin resistance measured by the plasma heparin thrombin time.

Authors:  T HOLGER-MADSEN
Journal:  Thromb Diath Haemorrh       Date:  1961-07-15

3.  Coagulability and thrombosis.

Authors:  L POLLER
Journal:  Clin Sci       Date:  1956-02       Impact factor: 6.124

4.  Mechanism of action of heparin as an etiological basis for homeostasis (hemorrhage and thrombosis).

Authors:  C E BRAMBEL; A H CORWIN; V A CAPONE
Journal:  Am J Med Sci       Date:  1955-09       Impact factor: 2.378

5.  The action of thromboplastic substances.

Authors:  R BIGGS; A S DOUGLAS; R G MACFARLANE
Journal:  J Physiol       Date:  1953-12-29       Impact factor: 5.182

6.  The antithrombin activity of heparin.

Authors:  J W LYTTLETON
Journal:  Biochem J       Date:  1954-09       Impact factor: 3.857

7.  Studies on Increased Coagulability of the Blood.

Authors:  T R Waugh; D W Ruddick
Journal:  Can Med Assoc J       Date:  1944-07       Impact factor: 8.262

8.  The nature of plasma antithrombin activity.

Authors:  P D KLEIN; W H SEEGERS
Journal:  Blood       Date:  1950-08       Impact factor: 22.113

9.  The effect of heparin on the early stages of blood coagulation.

Authors:  J R O'BRIEN
Journal:  J Clin Pathol       Date:  1960-03       Impact factor: 3.411
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.